ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 287513 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 287513; 2) Community: the network communities that were significantly associated with the response to NSC 287513; 3) Molecule: the relationships between components within communities and NSC 287513; 4) MDR: the compounds that were significantly associated with the NSC 287513.

NSC Compound Enrichment Correlation
NSC 719412 Null 0.0386895225700413 0.1945055
NSC 724601 S-(dimethylarsino)-3-mercapto-1,2-propyl dinonanoate 0.0386895225700413 -0.17343742
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0386895225700413 0.21002729
NSC 753190 3,5-dichloro-N-(4-(3-(4-chloro-3-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)benzamide 0.0386895225700413 -0.13031109
NSC 757306 Pyrimethamine (USAN) 0.0386895225700413 0.077553506
NSC 94600 Camptothecin 0.0386895225700413 0.37059195
NSC 11240 Aizen Victoria Blue BOH 0.0401206532535666 0.16998544
NSC 134727 MITOMYCIN C 0.0401206532535666 0.47474414
NSC 281279 Platinum, aqua(1,2-cyclohexanediamine-N,N')(tetraoxoselenato(2-)-O)-, (SP-4-3)- 0.0401206532535666 0.16003249
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.0401206532535671 0.1928614
Total:53  Current:42    [First] [Prev] [Next] [Last]